Welcome and Panel 1
Presiding Officer Opening Remarks
Douglas Throckmorton, MD
Deputy Center Director, Center for Drug Evaluation and Research, FDA
Theresa Kroll, Parent
Ada Giudice-Tompson, Patient Advocate
Avi Israel, Patient Advocate
Pete Jackson, Advocates for the Reform of Prescription Opioids
FDA Questions
Wendy Foster, U.S. Pain Foundation, Inc.
Zxy Atiywariii, Patient
Cynthia Ralls, Patient and Advocate
Sarah Bowker, Patient and Survivor
FDA Questions |
Play Flash Video
|
|
Panel 2
Robert Twillman, Health Professional Organization
Edward Manougian, Clinician
Ronald J. Crossno
American Academy of Hospice and Palliative Medicine
Charles Argoff, American Academy of Pain Medicine Foundation
FDA Questions
Edward Michna, American Pain Society and Harvard Medical School
Debra Carr, Clinician
Gwenn Herman, Clinician
Hillary Kunins, New York City Department of Health and Mental Hygiene
FDA Questions |
Play Flash Video
|
|
Panel 3
Andrew Kolodny, Physicians for Responsible Opioid Prescribing
Roland Gray, Clinician
Irfan Dhalla, University of Toronto and St. Michael’s Hospital
Michael Baron, Vanderbilt University
FDA Questions
Daniel Carr, American Society of Anesthesiologists
Michael Von Korff, Global Health Research Institute
Tara Gomes, Academia
Gregory Terman, University of Washington
FDA Questions |
Play Flash Video
|
|
Panel 4
Stephen Wood, Covectra, Inc.
Matt Ervin, MedicaSafe, Inc.
Kevin Zacharoff, Inflexxion
Jody Green, Denver Health and Hospital Authority
FDA Questions
Jeffrey White, Worker’s Compensation Insurance Company
Leland McClure, Quest Diagnostics
G. Caleb Alexander, Academia
Daniel Solomon, Harvard Medical School and Brigham and Women’s Hospital
FDA Questions
Adjourn for Day 1 |
Play Flash Video
|
|
Day 2 Panel 5
Opening Remarks
Dennis Capolongo, Arachnoiditis Society for Awareness and Prevention
Andrew Kowal, Tufts Medical School and Lahey Clinic
William Schmidt, Industry Consultant
David Bagnall, American Academy of Physical Medicine and Rehabilitation
FDA Questions
Patricia McDonald, Patient Advocate
Tish Westrup, Patient Advocate
Judy Rummler, Steve Rummler Hope Foundation
Lexi Reed Holtum, Steve Rummler Hope Foundation
FDA Questions |
Play Flash Video
|
|
Panel 6
Marianne Cloeren, American College of Occupational and Environmental Medicine
Jaime Threadgill, Pharmacist
Kevin Nicholson, National Association of Chain Drug Stores
Jack E. Henningfield, Pinney Associates
FDA Questions
David Egilman, Brown University
Miro Pavelka, American Association of Oral and Maxillofacial Surgeons
Richard Medlin, Academia and Clinician
Jane Ballantyne, Clinician
FDA Questions |
Play Flash Video
|
|
Panel 7
Anita Roach, Interstitial Cystitis Association
Fred Brason, Project Lazarus
Rebecca Kirch, American Cancer Society
Robert O’Connor, Emergency Room Physician
FDA Questions
Cheryl Placek, Parent
Randy Cohen, Patient
FDA Questions |
Play Flash Video
|
|
Open Public Hearing, Closing Remarks
|
Play Flash Video
|
|
|